COVID 19 PATIENTS
Farmer's son from small Tamil Nadu village builds Rs 1.5-crore software business after quitting nine-year Chennai IT career & starting with just two laptops
Eswaran Arumugam launched his Tamil Nadu-based software venture, Yaa Creations, with just Rs 1 lakh borrowed from his brother and two laptops. The business faced several hurdles, including financial strain, disruptions caused by the Covid-19 pandemic and accumulated debt of Rs 5 lakh. However, he gradually turned things around and expanded operations. Today, the company, headquartered in Rasipuram in Namakkal district, employs 26 people, serves clients in seven countries and completed projects worth Rs 1.5 crore in 2025.
Florida Learjet plane crash cut their love story short: They met at a hostel in Peru, fell in love and opened a hotel in Caribbean. Rachael Reed and Charmi Fehr's story
Rachael Reed and Charmi Fehr met at a hostel in Peru in 2019, fell in love and eventually built a life together on Honduras' island of Roatán, where they opened a boutique hotel in 2023. The couple, who shared a passion for travel and adventure, were among nine people killed in a Florida Learjet crash while travelling to the Bahamas. Their journey from a chance meeting to building a Caribbean hospitality business has been remembered by friends, family and hotel staff.
His grandfather died of pancreatic cancer: This Hyderabad startup founder is using AI to develop a personalised cancer vaccines
Hyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technology. Inspired partly by his family's experience with pancreatic cancer, he aims to help the immune system identify and attack cancer cells using treatments designed around individual patients' tumour genetics.
Most wanted stocks 2026: 6 stocks mutual funds are buying even as markets slump
Stock market investors are growing wary as prices continue to drop amid broader economic issues. Nevertheless, mutual fund managers are optimistic, identifying many investment opportunities during this downturn. The article identifies six stocks that have seen a rise in mutual fund investments, showcasing their resilience and growth potential during tough times. This analysis offers investors valuable insights to enhance their future strategies.
Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%
The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosystem charge. And both the government and the courts have stepped in. At one level, that is not entirely a bad thing. Check out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focusing on five key components – earnings, fundamentals, relative valuation, risk, and price momentum – to generate standardised scores. SR+ Reports is a complimentary offering to ETPrime members.
SCHOTT Pharma India marks a new chapter, building on its strong national presence and global capabilities
New identity reinforces the company’s focus on innovation, customer partnerships and pharmaceutical drug containment and delivery solutions
- Go To Page 1

US-friendly nations slash treasury purchases by 60%, led by Asia
In the first eight months of 2026, countries aligned with the US purchased a net total of $174.3 billion in Treasuries. This amount represents a significant decline, reflecting a drop of over 60% from the previous year. It marks the lowest investment level recorded for this period since 2021. The data highlights a shift in fiscal relationships between the US and its partners.

AI halves drug discovery times, but =trial bottleneck remains a costly reality
Novo Nordisk, Sanofi and Dr Reddy’s Laboratories are among the companies exploring applications ranging from drug discovery to laboratory automation and research.

ETMarkets Smart Talk | Investors want more than trading apps; they want a partner in their wealth journey: Shripal Shah
Shripal Shah, MD & CEO of Kotak Neo, discusses how investor behaviour has changed, why digital convenience alone is no longer enough, and how the next phase of broking will be shaped by connected investing, access to research and human expertise.

Dolly Parton started a foundation in 1995 to help young children read. Donated nearly 325 million books across the US, UK, and Canada; her father's inability inspired her
Dolly Parton, who passed away on August 25, 2026, left behind a significant philanthropic legacy. The Imagination Library, launched in 1995, has gifted over 325 million books to young children. This initiative started from her own father's literacy challenges and aimed to improve access to books. Furthermore, Parton contributed to healthcare and disaster relief, reflecting her commitment to service. Her work continues to influence children's literacy and community support.

The best financial advice is often to do nothing, says Value Research CEO Dhirendra Kumar
Value Research CEO Dhirendra Kumar says good financial advice often means helping investors avoid unnecessary transactions and impulsive decisions. Speaking at the Global Financial Planners Summit Team 2026 hosted by 1 Finance, he stressed the importance of financial education at home, disciplined investing and understanding products before making decisions with long-term financial consequences.

ET Startup Awards 2026: Deeptech wants government to step up as the first customer
At the discussion, titled ‘Building the Hard Stuff in India’, moderated by Accel partner Prashanth Prakash, founders from the space, semiconductor and healthtech sectors discussed the challenges of building capital-intensive technologies, developing domestic capabilities and taking complex products to market.

Our central mission must be patient-centric innovation: JP Nadda
J P Nadda urges industry to take discoveries ‘from bench to bedside’ as the FICCI–Lilly Bharat Life Sciences Award backs its inaugural cohort with ₹7 crore in grants

Russia Plague Explained: What do we know so far about the institute lab worker’s death?
A laboratory worker at Russia’s Irkutsk Anti-Plague Research Institute died after developing an unidentified form of pneumonia, triggering precautionary quarantine measures and social media speculation. Authorities have said there is no evidence she died of plague or that anyone she contacted was infected, while tests have so far found no plague cases linked to her.

When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%
Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends on what it chose in the last five or six. So, one name can do wonderfully while the one sitting next to it does very little. Stock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, fundamentals, relative valuation, risk, and price momentum – to generate standardised scores. The simple average of the above-mentioned five component ratings is normally distributed to reach an average score.

Russia quarantines Siberia hospital after plague lab worker dies of unknown pneumonia
Russian authorities have implemented a quarantine at a hospital where a lab technician died from pneumonia. The woman had worked at the Irkutsk Anti-Plague Research Institute in Siberia and raised concerns about a potential infectious disease. Health officials are monitoring individuals who had contact with her and have not confirmed any infectious source. Reports suggest she might have died from pneumonic plague, but this remains unverified.

India within striking distance of 8% GDP growth, resilience not accidental: Shaktikanta Das
With an ambitious target of 8% GDP growth, India aims for Viksit Bharat by the year 2047 through innovative reforms. The government is dedicated to increasing domestic capabilities in crucial areas such as energy and manufacturing. Significant measures are being implemented to strengthen long-term finance and bolster involvement in global supply chains.

2026 Nobel Prize Predictions: From GLP-1 drugs and CAR-T therapy to gene editing, these breakthroughs could take centre stage
Predictions for the 2026 Nobel Prizes in science highlight significant contributions in areas like GLP-1 research and cancer therapies. Carl June is mentioned for his role in developing CAR-T cell therapy for cancer treatment. Researchers Emmanuel Mignot and Masashi Yanagisawa are noted for their work on orexin related to sleep regulation. Optical coherence tomography and lipid nanoparticle technology are also strong candidates for recognition.

Nifty SIP return fails to beat even bank FD over 5 years: Is this the warning sign investors can’t ignore?
New insights reveal that systematic investment plans in the Nifty50 have consistently underperformed, presenting a five-year XIRR of merely 4.5%. This result places Nifty50 below the returns of traditional fixed deposits. In contrast, midcap and smallcap indices have shown impressive gains. Analysts recommend a strategy focusing on individual stock selection and earnings growth rather than relying solely on index performance, prompting a reassessment of index-based investment approaches.

Equity market correction nears 2 years: What history tells investors and what should they do - hold, buy or exit
Indian stock markets have languished with nearly two years of stagnant returns since late 2024. This lengthy phase of sideways trading serves as a necessary time correction rather than merely a decline in prices. Historical trends indicate that similar corrections have often extended much longer and deeper. Investors should exercise patience, persist with their SIP strategies, and recognize that moderating valuations and recovering earnings may herald promising future opportunities.

Covid ka chota bhai: Radiologist shares scan of a young patient showing the effects of H1N1 influenza spread across India, says it is not a harmless diesease
A doctor has shared an Instagram post featuring a CT scan that he claimed showed extensive lung infection in a young woman with influenza. Calling flu the “Chota bhai of Covid”, he warned that some patients may require hospitalisation or intensive care. He also shared five prevention tips, including masking in crowded places, healthy habits, adequate sleep and timely medical consultation.

COVID-19 patients staying longer at hospitals this time: Experts
The length of hospital stay — an indicator of the severity of a disease — has increased manifold in the second wave for reasons such as this, said experts. Hospitals have reported that a Covid-19 patient reporting moderate symptoms is spending 10-14 days and a severe patient could spend up to a month due to dependence on medical oxygen.

Maharashtra: 2 Covid-19 patients die as oxygen valve gets turned off
Two Covid-19 patients died after an oxygen supply valve was allegedly turned off by an unidentified person at the civil hospital in Beed district of Maharashtra, their relatives claimed on Saturday.

No COVID-19 patient in Maharashtra died due to oxygen shortage: Rajesh Tope
Earlier this week, kin of 10 COVID-19 patients who died at two hospitals in Palghar district neighbouring Mumbai had alleged that a shortage of oxygen led to the deaths.

Embarrassment for BMC as Jaslok Hospital says it will treat non-COVID patients as well
BMC had on Wednesday issued a circular, in which it had said that the Jaslok Hospital will no longer admit non-COVID-19 patients. However, the hospital issued a statement late night on Thursday, saying that it has increased the number of beds for coronavirus patients, but it would continue to treat other critically-ill patients also.

No directive for affixing posters outside homes of COVID-19 patients, Centre tells SC
The government said this before a bench headed by Justice Ashok Bhushan which reserved order on a plea seeking directions to do away with the practice of pasting posters outside the homes of those infected by coronavirus.

Steroid treatment should be reserved for sickest COVID-19 patients, say scientists
Scientists, including those from St. Jude Children's Research Hospital in the US, assessed the levels of the immune system protein cytokines, and other health markers in 168 adults with COVID-19, 26 adults with flu and 16 healthy volunteers.

Zydus Cadila completes phase 2 clinical trial in COVID-19 patients with biological therapy PegiHep
In a regulatory filing, Zydus Cadila said "it has successfully completed a phase 2 clinical trial in COVID-19 patients with its biological therapy, Pegylated Interferon alpha-2b, 'PegiHep'... Based upon the results from its Phase 2 study, Zydus Cadila now plans to conduct a phase 3 clinical trial in India".
Load More